Premier (NASDAQ:PINC) Releases FY 2025 Earnings Guidance

Premier (NASDAQ:PINC - Get Free Report) updated its FY 2025 earnings guidance on Tuesday. The company provided EPS guidance of 1.260-1.340 for the period, compared to the consensus EPS estimate of 1.290. The company issued revenue guidance of $940.0 million-$1.0 billion, compared to the consensus revenue estimate of $990.8 million.

Analyst Ratings Changes

PINC has been the topic of several analyst reports. Canaccord Genuity Group decreased their price objective on Premier from $21.00 to $19.00 and set a "hold" rating on the stock in a report on Wednesday. Barclays lifted their price target on Premier from $20.00 to $24.00 and gave the stock an "equal weight" rating in a research note on Wednesday, November 6th. Robert W. Baird cut their target price on shares of Premier from $20.00 to $19.00 and set a "neutral" rating on the stock in a report on Wednesday. Piper Sandler lowered their price target on shares of Premier from $21.00 to $19.00 and set a "neutral" rating for the company in a report on Wednesday. Finally, StockNews.com lowered shares of Premier from a "buy" rating to a "hold" rating in a report on Tuesday, November 5th. Ten equities research analysts have rated the stock with a hold rating, Based on data from MarketBeat, Premier presently has an average rating of "Hold" and a consensus price target of $20.50.

Premier Stock Performance

PINC stock traded down $0.19 on Friday, reaching $18.76. The company's stock had a trading volume of 1,808,690 shares, compared to its average volume of 1,351,971. The business has a fifty day simple moving average of $21.68 and a two-hundred day simple moving average of $20.93. The firm has a market cap of $1.80 billion, a PE ratio of 13.79 and a beta of 0.43. Premier has a 12-month low of $17.95 and a 12-month high of $23.56.

Premier (NASDAQ:PINC - Get Free Report) last announced its earnings results on Tuesday, November 5th. The company reported $0.34 earnings per share for the quarter, beating analysts' consensus estimates of $0.25 by $0.09. Premier had a net margin of 11.41% and a return on equity of 10.74%. The firm had revenue of $248.14 million for the quarter, compared to analyst estimates of $232.85 million. During the same quarter in the previous year, the firm posted $0.50 EPS. The company's revenue for the quarter was down 7.8% compared to the same quarter last year. As a group, research analysts anticipate that Premier will post 1.12 earnings per share for the current fiscal year.

Premier Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Saturday, March 15th. Shareholders of record on Saturday, March 1st will be given a dividend of $0.21 per share. The ex-dividend date of this dividend is Friday, February 28th. This represents a $0.84 annualized dividend and a yield of 4.48%. Premier's payout ratio is 61.77%.

Insider Transactions at Premier

In other news, Director John T. Bigalke sold 1,136 shares of Premier stock in a transaction dated Thursday, December 5th. The stock was sold at an average price of $22.19, for a total value of $25,207.84. Following the completion of the transaction, the director now owns 23,846 shares of the company's stock, valued at $529,142.74. The trade was a 4.55 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Helen M. Boudreau sold 2,500 shares of the stock in a transaction dated Monday, January 6th. The shares were sold at an average price of $21.42, for a total transaction of $53,550.00. Following the sale, the director now directly owns 20,668 shares in the company, valued at $442,708.56. This trade represents a 10.79 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last quarter, insiders sold 59,425 shares of company stock valued at $1,320,242. Corporate insiders own 0.96% of the company's stock.

Premier Company Profile

Premier, Inc, together with its subsidiaries, operates as a healthcare improvement company in the United States. It operates in two segments, Supply Chain Services and Performance Services. The Supply Chain Services segment offers its members with an access to a range of products and services, including medical and surgical products, pharmaceuticals, laboratory supplies, capital equipment, information technology, facilities and construction, and food and nutritional products, as well as purchased services, such as clinical engineering and workforce solutions.